AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) lost the point man for the commercial launch of its automated pain drug system on the eve of an FDA decision on the product. AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) net profit margin is -70.40% and weekly performance is -9.78%. On last trading day company shares ended up $8.30. Analysts mean target price for the company is $15.69. AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) distance from 50-day simple moving average (SMA50) is -18.83%.
Opko Health Inc. (NYSE:OPK) CEO Phillip Md Et Al Frost acquired 20,000 shares of Opko Health stock on the open market in a transaction dated Wednesday, June 4th. The stock was purchased at an average cost of $8.78 per share, for a total transaction of $175,600.00. Following the completion of the acquisition, the chief executive officer now directly owns 1,987,500 shares in the company, valued at approximately $17,450,250. Opko Health Inc. (NYSE:OPK) shares fell -0.22% in last trading session and ended the day on $9.23. OPK gross Margin is 43.40% and its return on assets is -10.50%.Opko Health Inc. (NYSE:OPK) quarterly performance is 0.44%.
Stryker Corporation (NYSE:SYK) Director Ronda E. Stryker unloaded 21,000 shares of Stryker stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $85.66, for a total transaction of $1,798,860.00. Following the completion of the transaction, the director now directly owns 174,605 shares in the company, valued at approximately $14,956,664. Stryker Corporation (NYSE:SYK) shares moved down -0.26% in last trading session and was closed at $85.56, while trading in range of $85.27 – $86.11. Stryker Corporation (NYSE:SYK) year to date (YTD) performance is 14.31%.
Hologic, Inc. (NASDAQ:HOLX) on 4 June announced that Stephen MacMillan, President and Chief Executive Officer, will present at the Goldman Sachs 35th Annual Global Healthcare Conference in Rancho Palos Verdes, California on Wednesday, June 11, 2014 at 4:20 p.m. Eastern Time. Hologic, Inc. (NASDAQ:HOLX) ended the last trading day at $24.90. Company weekly volatility is calculated as 1.30% and price to cash ratio as 14.20.Hologic, Inc. (NASDAQ:HOLX) showed a positive weekly performance of 1.88%.
MiMedx Group Inc. (NASDAQ:MDXG) announced on 4 June, Wednesday that the Board applauds the dismissal of the lawsuit brought by the Securities and Exchange Commission or SEC against the Company’s Chairman and CEO, Parker H. “Pete” Petit. MiMedx Group Inc. (NASDAQ:MDXG) net profit margin is -5.10% and weekly performance is 9.69%. On last trading day company shares ended up $6.00. Analysts mean target price for the company is $9.25. MiMedx Group Inc. (NASDAQ:MDXG) distance from 50-day simple moving average (SMA50) is 6.02%.